ClinicalTrials.gg
CompletedNCT04053686Updated Nov 13, 2020

An Intervention to Reduce Prolonged Sitting in Police Staff

An interventional study of Breaks in Sedentary Behavior, Metabolic Syndrome and Affect, sponsored by University of Bedfordshire. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-13.

Sponsored by University of Bedfordshire · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The primary aim of this study is to assess the feasibility of an intervention to reduce and break up prolonged sitting time in full-time police staff. The secondary aims of this study are to assess preliminary effects on patterns of sedentary behaviour (number of breaks, number of prolonged sitting bouts, average duration of prolonged sitting bouts, and total prolonged sitting duration), additional measures of sedentary behaviour (total sitting time, standing, and stepping), cardiometabolic risk markers, physiological stress (cortisol levels), physical health (self-report and postural stability), psychological wellbeing and mood, work stress (self-reported), and work performance (job satisfaction and productivity).

Read the detailed description

Prolonged sedentary behaviour is associated with a higher incidence of cardiovascular disease and type 2 diabetes. A large proportion of daily sedentary time (sitting) occurs in the workplace. On average, full time office workers spend upwards of 70% of their working day seated with the majority of this time accumulated in sitting bouts ≥ 20 minutes. A recent cross-sectional investigation into the occupational characteristics of over 5,000 British police force employees reported at least 30% identifying as having mainly office-based duties. When trying to reduce prolonged sitting in the workplace, one of the most effective strategies is the use of multi-component interventions. At the present time, sedentary workplace intervention studies in the police are limited.

The primary aim of this study is to assess the feasibility of an intervention to reduce and break up prolonged sitting time at work in full-time police staff. The secondary aims of this study are to assess preliminary effects on sedentary behaviour, cardiometabolic risk markers, physiological stress, physical health, psychological wellbeing and mood, work stress, and work performance.

This has a single-arm, pre-post study design. Participants will receive a multi-component intervention to break up and reduce prolonged sitting including: a presentation/workshop, electronic support, minor environmental modifications, organisational support, and team competition. Assessments will take place at baseline and post-intervention (week 10).

02

Conditions studied

  • Sedentary Behavior
  • Metabolic Syndrome
  • Affect
  • Stress, Physiological
  • Stress, Psychological
  • Musculoskeletal Pain
03

In context

Sedentary Behavior

1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.

This study's enrollment of 24 is below the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

University of Bedfordshire is the lead sponsor of 12 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ 0.6 Full Time Equivalent (FTE) work hours
  • Ambulatory
  • Predominantly desk-based (spend on average ≥ 5-h/day seated at work by self-report)
  • Own a smartphone, with ability to keep phone with them during work hours

Exclusion criteria

Exclusion Criteria:

  • Planned absence of two weeks or more during the intervention period
  • Work part time (\< 0.6 FTE)
  • Health to standing and walking
  • Planned relocation to another site, office or workplace
  • Have personal access to an active workstation (sit-stand desk, seat cycle, treadmill desk or similar)
  • Participating simultaneously in another workplace intervention (for sedentary behaviour, physical activity, diet, lifestyle, or combination thereof)
  • Health contraindications to postural stability testing (e.g., injury to the lower extremities in the past six months, dizziness, or epilepsy)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Intervention

    The intervention group will aim to regularly break up participants' prolonged sitting time with three-minute incidental movement breaks every half hour at work. Support for behaviour change will include a lecture/workshop, electronic prompts, break logging, team competition, health champions, and email support.

    Behavioral: Breaks

Interventions

  • BehavioralBreaks

    3-min breaks every half hour at work

06

What researchers measure

Primary outcomes

  1. Feasibility - Adherence: Drop-out rates in control and intervention group

    Analyses of drop-out rates (%) in control and intervention group.

    Time frame: From recruitment (typically 4 weeks prior to baseline) up to study completion (typically 12 weeks)

  2. Feasibility - Acceptability: Perceptions of the intervention

    Asking participants' to qualitatively reflect on the intervention via semi-structured interview.

    Time frame: At week 11

Secondary outcomes

  1. Change in the number of breaks (sit-stand transitions) from sedentary time per hour (workplace and daily)

    Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of sit-stand transitions.

    Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.

  2. Change in sitting time accrued in prolonged bouts (≥ 30 minutes) (workplace and daily)

    Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of sitting time accrued in prolonged bouts (≥ 30 minutes).

    Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.

  3. Change in the average duration (minutes) of prolonged sitting bouts (≥ 30 minutes) (workplace and daily)

    Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of the average duration (minutes) of prolonged sitting bouts (≥ 30 minutes).

    Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.

  4. Change in the number of prolonged sitting bouts (≥ 30 minutes) (workplace and daily)

    Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of the number of prolonged sitting bouts (≥ 30 minutes).

    Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.

  5. Change in the total duration (minutes) of sitting time (workplace and daily)

    Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of sitting time.

    Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.

  6. Change in step count (workplace and daily)

    Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of step count.

    Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.

  7. Change in total stepping time (in minutes) (workplace and daily)

    Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of total stepping time (in minutes).

    Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.

  8. Change in total standing time (in minutes) (workplace and daily)

    Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of total standing time (in minutes).

    Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.

  9. Weight (kg)

    Changes in weight via Tanita scale.

    Time frame: Baseline and at week 11

  10. Body mass index (BMI)

    Changes in BMI will be computed by dividing participants' weight (in kilograms) by their height (in metres) squared.

    Time frame: Baseline and at week 11

  11. Waist circumference (cm)

    Changes in waist circumference will be assessed by tape measure.

    Time frame: Baseline and at week 11

  12. Body fat %

    Changes in body fat percentage will be assessed via a bioelectric impedance spectroscopy device.

    Time frame: Baseline and at week 11

  13. Body fat mass (kg)

    Changes in body fat mass via a bioelectric impedance spectroscopy device.

    Time frame: Baseline and at week 11

  14. Lean body mass (kg)

    Changes in lean body mass via a bioelectric impedance spectroscopy device.

    Time frame: Baseline and at week 11

  15. Blood pressure (mmHg)

    Changes in blood pressure measured via electronic sphygmomanometer.

    Time frame: Baseline and at week 11

  16. Fasted blood cholesterol (mg/dL)

    Changes in total, high density lipoprotein (HDL), and low density lipoprotein (LDL) cholesterol measured via fasting blood tests using a Cholestech machine.

    Time frame: Baseline and at week 11

  17. Fasted blood triglycerides (mg/dL)

    Changes in triglycerides measured via fasting blood tests using a Cholestech machine.

    Time frame: Baseline and at week 11

  18. Fasted blood glucose (mg/dL)

    Changes in glucose levels measured via fasting blood tests using a Cholestech machine.

    Time frame: Baseline and at week 11

  19. Salivary cortisol (nmol/L)

    Changes in the cortisol awakening response and diurnal cortisol levels will be assessed via saliva samples (provided by chewing on a cotton swab for 60secs) collected seven times over the course of one day.

    Time frame: Baseline and at week 11. At each time point saliva samples will be collected at 7 time points over the course of one day.

  20. Nordic musculoskeletal questionnaire

    The Nordic musculoskeletal questionnaire is comprised of 40 forced-choice questions pertaining to low back, neck, shoulder and general physical complaints most often experienced in the work setting. A visual diagram aids the viewer by labelling the nine regions of the body referred to in the questionnaire. Acceptable reliability for this tool has been demonstrated.

    Time frame: Baseline and at week 11

  21. Postural sway velocity (mm/s)

    Change in postural sway velocity (bipedal-eyes-open, bipedal-eyes-closed, unipedal-eyes-open, unipedal-eyes-closed) will be evaluated via dynamic plantar pressure sensor (RS Footscan).

    Time frame: Baseline and at week 11

  22. Postural sway range (mm)

    Change in postural sway range (bipedal-eyes-open, bipedal-eyes-closed, unipedal-eyes-open, unipedal-eyes-closed) will be evaluated via dynamic plantar pressure sensor (RS Footscan).

    Time frame: Baseline and at week 11

  23. International Physical Activity Questionnaire short form (IPAQ)

    Changes in self-reported physical activity and total sitting time. The International Physical Activity Questionnaire short form (IPAQ) measures self-reported physical activity and sitting time in the last seven days. Participants are asked to report frequency of participation (0-7 days) and duration of activity on one of those days (in hours and minutes). The IPAQ has demonstrated acceptable reliability and validity in measuring activity in the last seven days.

    Time frame: Baseline and at week 11

  24. Marshall sitting questionnaire

    The Marshall sitting questionnaire has five questions that measure self-reported domain-specific sitting time (hours and minutes) on weekend days and weekdays. This questionnaire has good reliability and validity for sitting time on weekdays and weekend days.

    Time frame: Baseline and at week 11

  25. Warwick-Edinburgh mental well-being scale (WEMWBS)

    The Warwick-Edinburgh mental well-being scale (WEMWBS) is a 14-item questionnaire used to assess various aspects of positive mental health (e.g., "I've been feeling optimistic about the future"). Participants are asked to rate their experience of each wellbeing statement between 1 and 5 (1 = none of the time and 5 = all of the time). Item scores are then combined to provide a total score (between 14 - 70). The higher the score the better the overall mental wellbeing. For intervention purposes, a change in the total score of 3-8 points between two time points may be considered a "meaningful change".

    Time frame: Baseline and at week 11

  26. Positive and negative affect schedule (PANAS)

    Changes in self-reported mood via the positive and negative affect schedule (PANAS) consisting of two 10-item subscales to measure positive and negative affect (i.e., mood). A number of words that describe different feelings and emotions (e.g., "interested", "distressed", "excited") are presented and participants are asked to indicate on a 5-point scale to what extent over the past week they have felt these feelings/emotions (1 = very slightly or not at all and 5 = extremely). These scales are internally consistent with very good convergent and discriminant correlations. Negative Affect subscale Item scores on the negative affect scale are then combined to provide a total score (between 10 - 50). The higher the score the more negative emotions experienced. Positive Affect subscale Item scores on the positive affect scale are then combined to provide a total score (between 10 - 50). The higher the score the more positive emotions experienced.

    Time frame: Baseline and at week 11

  27. Operational police stress questionnaire (PSQ-Op)

    Changes in ratings of 20 operational stressors for police (PSQ-Org). Participants will be asked to rate items on "how much stress it has caused you over the past 6 months" using a 7-point Likert scale (1 = no stress at all and 7 = a lot of stress). Item scores are then combined to provide a total score (between 20 - 140). The higher the score the worse the stress level. This instrument has demonstrated acceptable reliability and validity for measuring police-specific occupational stressors.

    Time frame: Baseline and at week 11

  28. Organisational police stress questionnaire (PSQ-Org)

    Changes in ratings of 20 organisational stressors for police (PSQ-Org). Participants will be asked to rate items on "how much stress it has caused you over the past 6 months" using a 7-point Likert scale (1 = no stress at all and 7 = a lot of stress). Item scores are then combined to provide a total score (between 20 - 140). The higher the score the worse the stress level. This instrument has demonstrated acceptable reliability and validity for measuring police-specific occupational stressors.

    Time frame: Baseline and at week 11

  29. Job satisfaction

    Changes in self-reported job satisfaction and will be evaluated via a single-item questionnaire ("How satisfied are you with your job in general?") assessed on a 7-point Likert scale (1 = dissatisfied and 7 = extremely satisfied). A higher score represents more satisfaction with one's job.

    Time frame: Baseline and at week 11

  30. Job performance

    Changes in self-reported job performance will be evaluated via a single-item questionnaire ("How well do you think you have performed in your job recently?") with a 7-point Likert scale (1 = very poorly and 7 = extremely well). A higher score represents a more positive assessment of job performance.

    Time frame: Baseline and at week 11

07

Study locations

1 site
  • University of Bedfordfordshire
    Bedford, Bedfordshire MK41 9EA, United Kingdom
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2019 to primary completion in Dec 2019, 3 months.

Of 733 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's 3 months is below that.

Counting every sponsor, half of 741 studies reached it within 14 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2019
First posted
Aug 12, 2019
StartActual
Sep 9, 2019
Primary completionActual
Dec 20, 2019
CompletionActual
Dec 20, 2019
Last update
Nov 13, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04053686
Lead sponsor
University of Bedfordshire
Responsible party
Marsha Brierley (PhD Student, University of Bedfordshire) — Principal investigator
First posted
Aug 12, 2019
Start date
Sep 9, 2019
Primary completion
Dec 20, 2019
Completion
Dec 20, 2019
Last update
Nov 13, 2020

Study contacts

Daniel Bailey, PhD
principal investigator · University of Bedfordshire

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion